UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Time to diagnosis and factors affecting diagnostic delay in amyotrophic lateral sclerosis

Journal of the neurological sciences, 2020-10, Vol.417, p.117054-117054, Article 117054

2020

Volltextzugriff (PDF)

Differing patterns of cortical grey matter pathology identified by multifractal analysis in UMN-predominant ALS patients with and without corticospinal tract hyperintensity

Journal of the neurological sciences, 2024-04, Vol.459, p.122945-122945, Article 122945

2024

Volltextzugriff (PDF)

Graph network measures reveal distinct white matter abnormalities in motor and extra-motor brain regions of two UMN-predominant ALS subtypes

Journal of the neurological sciences, 2023-09, Vol.452, p.120765-120765, Article 120765

2023

Volltextzugriff (PDF)

Hypometabolic and hypermetabolic brain regions in patients with ALS-FTD show distinct patterns of grey and white matter degeneration: A pilot multimodal neuroimaging study

European journal of radiology, 2023-01, Vol.158, p.110616-110616, Article 110616

2023

Volltextzugriff (PDF)

Comparing brain structural MRI and metabolic FDG-PET changes in patients with ALS-FTD: ‘the chicken or the egg?’ question

Journal of neurology, neurosurgery and psychiatry, 2015-09, Vol.86 (9), p.952-958

2015

Volltextzugriff (PDF)

Trajectories of impairment in amyotrophic lateral sclerosis: Insights from the Pooled Resource Open‐Access ALS Clinical Trials cohort

Muscle & nerve, 2018-06, Vol.57 (6), p.937-945

2018

Volltextzugriff (PDF)

Self-reported factors contributing to delay in ALS diagnosis among primary care providers in a large Ohio-based US healthcare network

Journal of the neurological sciences, 2023-02, Vol.445, p.120532-120532, Article 120532

2023

Volltextzugriff (PDF)

Laughter, crying and sadness in ALS

Journal of neurology, neurosurgery and psychiatry, 2017-10, Vol.88 (10), p.825-831

2017

Volltextzugriff (PDF)

Real-world evidence of riluzole effectiveness in treating amyotrophic lateral sclerosis

Amyotrophic lateral sclerosis and frontotemporal degeneration, 2020-10, Vol.21 (7-8), p.509-518

2020

Volltextzugriff (PDF)

Graph theory network analysis provides brain MRI evidence of a partial continuum of neurodegeneration in patients with UMN-predominant ALS and ALS-FTD

NeuroImage clinical, 2022-01, Vol.35, p.103037-103037, Article 103037

2022

Volltextzugriff (PDF)

Pesticides applied to crops and amyotrophic lateral sclerosis risk in the U.S

Neurotoxicology (Park Forest South), 2021-12, Vol.87, p.128-135

2021

Volltextzugriff (PDF)

Depression in ALS in a large self-reporting cohort

Neurology, 2016-03, Vol.86 (11), p.1031-1038

2016

Volltextzugriff (PDF)

Neuroimaging in primary lateral sclerosis

Amyotrophic lateral sclerosis and frontotemporal degeneration, 2020-11, Vol.21 (S1), p.18-27

2020

Volltextzugriff (PDF)

Degeneration of gray and white matter differs between hypometabolic and hypermetabolic brain regions in a patient with ALS-FTD: a longitudinal MRI − PET multimodal study

Amyotrophic lateral sclerosis and frontotemporal degeneration, 2021-01, Vol.22 (1-2), p.127-132

2021

Volltextzugriff (PDF)

The effects of intervention with intravenous edaravone in Study 19 on hospitalization, tracheostomy, ventilation, and death in patients with amyotrophic lateral sclerosis

Muscle & nerve, 2023-10, Vol.68 (4), p.397-403

2023

Volltextzugriff (PDF)

Long‐term edaravone efficacy in amyotrophic lateral sclerosis: Post‐hoc analyses of Study 19 (MCI186‐19)

Muscle & nerve, 2020-02, Vol.61 (2), p.218-221

2020

Volltextzugriff (PDF)

Brain white matter shape changes in amyotrophic lateral sclerosis (ALS): a fractal dimension study

PloS one, 2013-09, Vol.8 (9), p.e73614-e73614

2013

Volltextzugriff (PDF)

Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS

Neurology, 2020-07, Vol.95 (1), p.e59

2020

Volltextzugriff (PDF)

Disparate voxel based morphometry (VBM) results between SPM and FSL softwares in ALS patients with frontotemporal dementia: which VBM results to consider?

BMC neurology, 2015-03, Vol.15 (1), p.32-32, Article 32

2015

Volltextzugriff (PDF)

Unbiased MRI Analyses Identify Micropathologic Differences Between Upper Motor Neuron-Predominant ALS Phenotypes

Frontiers in neuroscience, 2019-07, Vol.13, p.704-704

2019

Volltextzugriff (PDF)

Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials

Neurology, 2019-04, Vol.92 (14), p.e1610

2019

Volltextzugriff (PDF)

Dextromethorphan Plus Ultra Low-Dose Quinidine Reduces Pseudobulbar Affect

Annals of neurology, 2010-11, Vol.68 (5), p.693-702

2010

Volltextzugriff (PDF)

Control of microglial neurotoxicity by the fractalkine receptor

Nature neuroscience, 2006-07, Vol.9 (7), p.917-924

2006

Volltextzugriff (PDF)

Current Concepts in the Pharmacotherapy of Pseudobulbar Affect

Drugs (New York, N.Y.), 2011-01, Vol.71 (9), p.1193-1207

Pioro, Erik P.

2011

Volltextzugriff (PDF)

MR Imaging-based Estimation of Upper Motor Neuron Density in Patients with Amyotrophic Lateral Sclerosis: A Feasibility Study

Radiology, 2018-06, Vol.287 (3), p.955-964

2018

Volltextzugriff (PDF)

1 – 25 von 210

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(190)
Mit Volltextzugriff
(115)

Publikationsform

Sprache

Englisch
(210)
Japanisch
(23)

Erscheinungsjahr

n.n

Thema

Science & Technology
(147)
Life Sciences & Biomedicine
(140)
Neurosciences & Neurology
(121)
Humans
(108)
Clinical Neurology
(97)
Amyotrophic Lateral Sclerosis
(56)
Male
(51)
Neurosciences
(50)
Female
(46)
Middle Aged
(43)
Adult
(34)
Aged
(34)
Amyotrophic Lateral Sclerosis - Drug Therapy
(28)
Animals
(28)
Neurology
(26)
Amyotrophic Lateral Sclerosis - Diagnosis
(25)
Biological And Medical Sciences
(25)
Disease Progression
(21)
Medical Sciences
(18)
Magnetic Resonance Imaging
(17)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Time to diagnosis and factors affecting diagnostic delay in amyotrophic lateral sclerosis

Differing patterns of cortical grey matter pathology identified by multifractal analysis in UMN-predominant ALS patients with and without corticospinal tract hyperintensity

Graph network measures reveal distinct white matter abnormalities in motor and extra-motor brain regions of two UMN-predominant ALS subtypes

Hypometabolic and hypermetabolic brain regions in patients with ALS-FTD show distinct patterns of grey and white matter degeneration: A pilot multimodal neuroimaging study

Comparing brain structural MRI and metabolic FDG-PET changes in patients with ALS-FTD: ‘the chicken or the egg?’ question

Trajectories of impairment in amyotrophic lateral sclerosis: Insights from the Pooled Resource Open‐Access ALS Clinical Trials cohort

Self-reported factors contributing to delay in ALS diagnosis among primary care providers in a large Ohio-based US healthcare network

Laughter, crying and sadness in ALS

Real-world evidence of riluzole effectiveness in treating amyotrophic lateral sclerosis

Graph theory network analysis provides brain MRI evidence of a partial continuum of neurodegeneration in patients with UMN-predominant ALS and ALS-FTD

Pesticides applied to crops and amyotrophic lateral sclerosis risk in the U.S

Depression in ALS in a large self-reporting cohort

Neuroimaging in primary lateral sclerosis

Degeneration of gray and white matter differs between hypometabolic and hypermetabolic brain regions in a patient with ALS-FTD: a longitudinal MRI − PET multimodal study

The effects of intervention with intravenous edaravone in Study 19 on hospitalization, tracheostomy, ventilation, and death in patients with amyotrophic lateral sclerosis

Long‐term edaravone efficacy in amyotrophic lateral sclerosis: Post‐hoc analyses of Study 19 (MCI186‐19)

Brain white matter shape changes in amyotrophic lateral sclerosis (ALS): a fractal dimension study

Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS

Disparate voxel based morphometry (VBM) results between SPM and FSL softwares in ALS patients with frontotemporal dementia: which VBM results to consider?

Unbiased MRI Analyses Identify Micropathologic Differences Between Upper Motor Neuron-Predominant ALS Phenotypes

Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials

Dextromethorphan Plus Ultra Low-Dose Quinidine Reduces Pseudobulbar Affect

Control of microglial neurotoxicity by the fractalkine receptor

Current Concepts in the Pharmacotherapy of Pseudobulbar Affect

MR Imaging-based Estimation of Upper Motor Neuron Density in Patients with Amyotrophic Lateral Sclerosis: A Feasibility Study

Suchergebnisse filtern